Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
2
×
clinical trials
detroit blog main
detroit top stories
eisai
2
×
fda
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
89bio
abbvie
adrian krainer
alexion pharmaceuticals
alzheimer europe conference
alzheimer's disease
arena pharmaceuticals
astrazeneca
bain capital
What
drug
alzheimer’s
annual
assessed
attention
bio
biotech
cancer
communities
conference
eisai
esmo
europe
fda
flags
germany
higher
hosted
incidence
investment
lorcaserin
loss
market
marketing
medicine
munich
patients
post
prices
pulls
puzzle
research
risks
roundup
study
took
turned
week
weight
withdrawing
Language
unset
Current search:
eisai
×
cancer
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
